High Frequency of HIV Mutations Associated with HLA-C Suggests Enhanced HLA-C–Restricted CTL Selective Pressure Associated with an AIDS-Protective Polymorphism
Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C Ag. This polymorphism was recently shown to be a marker for a protective variant in the 3′UTR of HLA-C that disrupts a microRNA b...
Saved in:
Published in | The Journal of immunology (1950) Vol. 188; no. 9; pp. 4663 - 4670 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.05.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C Ag. This polymorphism was recently shown to be a marker for a protective variant in the 3′UTR of HLA-C that disrupts a microRNA binding site, resulting in enhanced HLA-C expression at the cell surface. Whether individuals with “high” HLA-C expression show a stronger HLA-C–restricted immune response exerting better viral control than that of their counterparts has not been established. We hypothesized that the magnitude of the HLA-C–restricted immune pressure on HIV would be greater in subjects with highly expressed HLA-C alleles. Using a cohort derived from a unique narrow source epidemic in China, we identified mutations in HIV proviral DNA exclusively associated with HLA-C, which were used as markers for the intensity of the immune pressure exerted on the virus. We found an increased frequency of mutations in individuals with highly expressed HLA-C alleles, which also correlated with IFN-γ production by HLA-C–restricted CD8+ T cells. These findings show that immune pressure on HIV is stronger in subjects with the protective genotype and highlight the potential role of HLA-C–restricted responses in HIV control. This is, to our knowledge, the first in vivo evidence supporting the protective role of HLA-C–restricted responses in nonwhites during HIV infection. |
---|---|
AbstractList | Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C Ag. This polymorphism was recently shown to be a marker for a protective variant in the 3'UTR of HLA-C that disrupts a microRNA binding site, resulting in enhanced HLA-C expression at the cell surface. Whether individuals with "high" HLA-C expression show a stronger HLA-C-restricted immune response exerting better viral control than that of their counterparts has not been established. We hypothesized that the magnitude of the HLA-C-restricted immune pressure on HIV would be greater in subjects with highly expressed HLA-C alleles. Using a cohort derived from a unique narrow source epidemic in China, we identified mutations in HIV proviral DNA exclusively associated with HLA-C, which were used as markers for the intensity of the immune pressure exerted on the virus. We found an increased frequency of mutations in individuals with highly expressed HLA-C alleles, which also correlated with IFN- gamma production by HLA-C-restricted CD8+ T cells. These findings show that immune pressure on HIV is stronger in subjects with the protective genotype and highlight the potential role of HLA-C-restricted responses in HIV control. This is, to our knowledge, the first in vivo evidence supporting the protective role of HLA-C-restricted responses in nonwhites during HIV infection. Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C Ag. This polymorphism was recently shown to be a marker for a protective variant in the 3'UTR of HLA-C that disrupts a microRNA binding site, resulting in enhanced HLA-C expression at the cell surface. Whether individuals with "high" HLA-C expression show a stronger HLA-C-restricted immune response exerting better viral control than that of their counterparts has not been established. We hypothesized that the magnitude of the HLA-C-restricted immune pressure on HIV would be greater in subjects with highly expressed HLA-C alleles. Using a cohort derived from a unique narrow source epidemic in China, we identified mutations in HIV proviral DNA exclusively associated with HLA-C, which were used as markers for the intensity of the immune pressure exerted on the virus. We found an increased frequency of mutations in individuals with highly expressed HLA-C alleles, which also correlated with IFN-γ production by HLA-C-restricted CD8(+) T cells. These findings show that immune pressure on HIV is stronger in subjects with the protective genotype and highlight the potential role of HLA-C-restricted responses in HIV control. This is, to our knowledge, the first in vivo evidence supporting the protective role of HLA-C-restricted responses in nonwhites during HIV infection. Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C antigen. This polymorphism was recently shown to be a marker for a protective variant in the 3′UTR of HLA-C that disrupts a microRNA binding site, resulting in enhanced HLA-C expression at the cell surface. Whether individuals with ‘high’ HLA-C expression show a stronger HLA-C-restricted immune response exerting better viral control than that of their counterparts has not been established. We hypothesised that the magnitude of the HLA-C-restricted immune pressure on HIV would be greater in subjects with highly expressed HLA-C alleles. Using a cohort derived from a unique narrow source epidemic in China, we identified mutations in HIV proviral DNA exclusively associated with HLA-C which were used as markers for the intensity of the immune pressure exerted on the virus. We found an increased frequency of mutations in individuals with highly expressed HLA-C alleles which also correlated with IFN-γ production by HLA-C-restricted CD8+ T-cells. These findings show that immune pressure on HIV is stronger in subjects with the protective genotype and highlights the potential role of HLA-C-restricted responses in HIV control. This is the first in vivo evidence supporting the protective role of HLA-C-restricted responses in non-Caucasians during HIV infection. Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C Ag. This polymorphism was recently shown to be a marker for a protective variant in the 3'UTR of HLA-C that disrupts a microRNA binding site, resulting in enhanced HLA-C expression at the cell surface. Whether individuals with "high" HLA-C expression show a stronger HLA-C-restricted immune response exerting better viral control than that of their counterparts has not been established. We hypothesized that the magnitude of the HLA-C-restricted immune pressure on HIV would be greater in subjects with highly expressed HLA-C alleles. Using a cohort derived from a unique narrow source epidemic in China, we identified mutations in HIV proviral DNA exclusively associated with HLA-C, which were used as markers for the intensity of the immune pressure exerted on the virus. We found an increased frequency of mutations in individuals with highly expressed HLA-C alleles, which also correlated with IFN-γ production by HLA-C-restricted CD8(+) T cells. These findings show that immune pressure on HIV is stronger in subjects with the protective genotype and highlight the potential role of HLA-C-restricted responses in HIV control. This is, to our knowledge, the first in vivo evidence supporting the protective role of HLA-C-restricted responses in nonwhites during HIV infection.Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C Ag. This polymorphism was recently shown to be a marker for a protective variant in the 3'UTR of HLA-C that disrupts a microRNA binding site, resulting in enhanced HLA-C expression at the cell surface. Whether individuals with "high" HLA-C expression show a stronger HLA-C-restricted immune response exerting better viral control than that of their counterparts has not been established. We hypothesized that the magnitude of the HLA-C-restricted immune pressure on HIV would be greater in subjects with highly expressed HLA-C alleles. Using a cohort derived from a unique narrow source epidemic in China, we identified mutations in HIV proviral DNA exclusively associated with HLA-C, which were used as markers for the intensity of the immune pressure exerted on the virus. We found an increased frequency of mutations in individuals with highly expressed HLA-C alleles, which also correlated with IFN-γ production by HLA-C-restricted CD8(+) T cells. These findings show that immune pressure on HIV is stronger in subjects with the protective genotype and highlight the potential role of HLA-C-restricted responses in HIV control. This is, to our knowledge, the first in vivo evidence supporting the protective role of HLA-C-restricted responses in nonwhites during HIV infection. |
Author | Blais, Marie-Eve Yan, Huiping Rowland-Jones, Sarah L Wu, Hao John, Mina Griffin, Harry Dong, Tao Taylor, Stephen Xu, Keyi Zhang, Yonghong James, Ian Rostron, Tim |
AuthorAffiliation | MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK OX3 9DS Beijing Ditan Hospital, Capital Medical University, Beijing, PRC Computational Biochemistry Research Group (CBRG), Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK OX3 9DS Centre for Clinical Immunology and Biomedical Statistics, Institute for Immunology & Infectious Diseases, Murdoch University & Royal Perth Hospital, WA, 6155, Australia Beijing You’An Hospital, Capital Medical University, Beijing, PRC Nuffield Department of Medicine (NDM), John Radcliffe Hospital, Oxford, UK OX3 9DS |
AuthorAffiliation_xml | – name: Beijing Ditan Hospital, Capital Medical University, Beijing, PRC – name: Computational Biochemistry Research Group (CBRG), Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK OX3 9DS – name: Beijing You’An Hospital, Capital Medical University, Beijing, PRC – name: Nuffield Department of Medicine (NDM), John Radcliffe Hospital, Oxford, UK OX3 9DS – name: MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK OX3 9DS – name: Centre for Clinical Immunology and Biomedical Statistics, Institute for Immunology & Infectious Diseases, Murdoch University & Royal Perth Hospital, WA, 6155, Australia |
Author_xml | – sequence: 1 givenname: Marie-Eve surname: Blais fullname: Blais, Marie-Eve – sequence: 2 givenname: Yonghong surname: Zhang fullname: Zhang, Yonghong – sequence: 3 givenname: Tim surname: Rostron fullname: Rostron, Tim – sequence: 4 givenname: Harry surname: Griffin fullname: Griffin, Harry – sequence: 5 givenname: Stephen surname: Taylor fullname: Taylor, Stephen – sequence: 6 givenname: Keyi surname: Xu fullname: Xu, Keyi – sequence: 7 givenname: Huiping surname: Yan fullname: Yan, Huiping – sequence: 8 givenname: Hao surname: Wu fullname: Wu, Hao – sequence: 9 givenname: Ian surname: James fullname: James, Ian – sequence: 10 givenname: Mina surname: John fullname: John, Mina – sequence: 11 givenname: Tao surname: Dong fullname: Dong, Tao – sequence: 12 givenname: Sarah L surname: Rowland-Jones fullname: Rowland-Jones, Sarah L |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22474021$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUs1uEzEYtFARTQt3TshHLls-e3ft3QtSFFoSKYiKFK6W4_VmXe3awfYW5cY78AS8Gk-CSxLEj5DwxdL3zYxHnjlDJ9ZZjdBTAhcFFPWLWzMMo3X9BSGQF5w-QBNSlpAxBuwETQAozQhn_BSdhXALAAxo8QidUlrwAiiZoK9zs-nwldcfR23VDrsWzxcf8JsxymicDXgaglNGRt3gTyZ2eL6cZjO8GjcbHWLAl7aTVqXlj_m3z1_epbE36h4_u1nile61iuZO42uvQxi9_ktRWjxdvFpl197FI9b1u8H5bWfC8Bg9bGUf9JPDfY7eX13ezObZ8u3rxWy6zFRB65jlVV7Kkteq1jUrOeV12QBXLXAoQOYKcsnXBNoc6pJp3rBqXTWMtI0smnTq_By93Otux_WgG6Vt9LIXW28G6XfCSSN-31jTiY27E3nOK1ZWSeD5QcC79JshisEEpfteWu3GIAiQIuWU3v8PKFQVrUpGE_TZr7Z--jlGmABsD1DeheB1K5TZh5dcmj5pifuuiGNXxKEriQh_EI_a_6R8B6rRxq4 |
CitedBy_id | crossref_primary_10_1016_j_celrep_2016_10_075 crossref_primary_10_3389_fimmu_2020_601089 crossref_primary_10_1128_JVI_02600_13 crossref_primary_10_1073_pnas_1312237110 crossref_primary_10_1038_ni_3147 crossref_primary_10_1093_hmg_ddv158 crossref_primary_10_3389_fimmu_2017_00746 crossref_primary_10_1126_science_1232685 crossref_primary_10_3389_fimmu_2018_02735 crossref_primary_10_3389_fgene_2022_862642 crossref_primary_10_1016_j_jim_2015_01_005 crossref_primary_10_1097_01_aids_0000432536_85335_c8 crossref_primary_10_1371_journal_pone_0255834 crossref_primary_10_4049_jimmunol_1700697 crossref_primary_10_1371_journal_pone_0127867 crossref_primary_10_3390_jcm11071887 crossref_primary_10_1016_j_humimm_2014_04_003 crossref_primary_10_1126_science_1241266 crossref_primary_10_1146_annurev_med_052511_135400 crossref_primary_10_1038_srep42470 crossref_primary_10_7554_eLife_69198 crossref_primary_10_1016_j_chom_2016_04_005 crossref_primary_10_3389_fimmu_2017_01496 crossref_primary_10_4049_jimmunol_1601679 crossref_primary_10_1016_j_humimm_2018_10_002 crossref_primary_10_1128_JVI_01711_17 crossref_primary_10_1128_mBio_00782_20 crossref_primary_10_3389_fimmu_2018_01316 crossref_primary_10_3389_fimmu_2014_00547 crossref_primary_10_1097_QAD_0000000000000574 crossref_primary_10_1126_science_1241854 crossref_primary_10_1016_j_meegid_2021_105180 crossref_primary_10_3390_cells10113108 crossref_primary_10_1016_j_chom_2017_06_008 crossref_primary_10_1111_imr_12071 crossref_primary_10_1038_srep10879 crossref_primary_10_1111_tan_12882 crossref_primary_10_1111_tan_13971 |
Cites_doi | 10.1038/ng.486 10.1126/science.1069660 10.1126/science.1195271 10.1084/jem.176.4.937 10.1371/journal.pone.0003636 10.1016/j.virol.2010.06.002 10.1182/blood-2006-06-030668 10.1038/ng.694 10.1371/journal.pgen.1000791 10.1038/nature03113 10.1089/aid.1995.11.1221 10.1002/eji.200939634 10.1038/nm992 10.1038/nature07746 10.1002/eji.201040841 10.1371/journal.pone.0023603 10.1128/JVI.00619-10 10.1038/nature09914 10.1126/science.1143767 10.1002/hep.23101 10.1038/344439a0 10.1084/jem.20090365 10.1182/blood-2010-06-291963 10.1371/journal.ppat.1001033 10.1111/j.1365-2567.2011.03422.x 10.4049/jimmunol.1100316 10.1038/ng.311 10.4049/jimmunol.1100691 10.1128/JVI.02276-10 10.1097/QAD.0b013e328325d414 10.1016/S1074-7613(00)80065-5 10.4049/jimmunol.181.10.6770 10.1084/jem.20032044 10.1111/j.1365-2567.2011.03474.x |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 7U9 H94 5PM |
DOI | 10.4049/jimmunol.1103472 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts Virology and AIDS Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1550-6606 |
EndPage | 4670 |
ExternalDocumentID | PMC3378658 22474021 10_4049_jimmunol_1103472 |
Genre | Multicenter Study Clinical Trial Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: Medical Research Council grantid: G0600520 – fundername: Medical Research Council grantid: G1001046 – fundername: Medical Research Council grantid: G0801751 – fundername: Medical Research Council : grantid: G0801751(88451) || MRC_ |
GroupedDBID | --- -~X .55 0R~ 18M 1KJ 2WC 34G 39C 3O- 53G 5GY 5RE 5VS 5WD 79B 85S AARDX AAYXX ABCQX ABDFA ABEJV ABGNP ABJNI ABOCM ABPPZ ABXVV ACGFO ACGFS ACIWK ACNCT ACPRK ADBBV ADIPN ADNWM AENEX AETEA AFHIN AFOSN AFRAH AGORE AHMMS AHWXS AIZAD ALMA_UNASSIGNED_HOLDINGS ARBBW BAWUL BCRHZ BTFSW CITATION D0L DIK DU5 E3Z EBS EJD F5P FRP GX1 IH2 K-O KQ8 L7B OCZFY OK1 OWPYF P0W P2P PQQKQ R.V RHI ROX RZQ SJN TR2 TWZ W8F WH7 WOQ X7M XJT XSW XTH YHG CGR CUY CVF ECM EIF NPM 7X8 7T5 7U9 H94 5PM |
ID | FETCH-LOGICAL-c429t-3835a579c9e96572795d07cf07040a3c03a7b10f30956e7d68b8d61fda4dddd93 |
ISSN | 0022-1767 1550-6606 |
IngestDate | Thu Aug 21 18:01:20 EDT 2025 Fri Jul 11 04:17:39 EDT 2025 Fri Jul 11 11:38:49 EDT 2025 Mon Jul 21 05:18:11 EDT 2025 Thu Apr 24 22:58:45 EDT 2025 Tue Jul 01 05:12:56 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
License | https://academic.oup.com/pages/standard-publication-reuse-rights |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c429t-3835a579c9e96572795d07cf07040a3c03a7b10f30956e7d68b8d61fda4dddd93 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 TD and SRJ equally collaborated to this work. |
OpenAccessLink | https://www.jimmunol.org/content/jimmunol/188/9/4663.full.pdf |
PMID | 22474021 |
PQID | 1008828562 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3378658 proquest_miscellaneous_1014110095 proquest_miscellaneous_1008828562 pubmed_primary_22474021 crossref_citationtrail_10_4049_jimmunol_1103472 crossref_primary_10_4049_jimmunol_1103472 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-05-01 |
PublicationDateYYYYMMDD | 2012-05-01 |
PublicationDate_xml | – month: 05 year: 2012 text: 2012-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | The Journal of immunology (1950) |
PublicationTitleAlternate | J Immunol |
PublicationYear | 2012 |
References | Kulkarni (2025032410071712000_r6) 2011; 472 Moore (2025032410071712000_r13) 2002; 296 Kaye (2025032410071712000_r28) 1995; 11 Stojakovic (2025032410071712000_r34) 2008; 181 Mkhwanazi (2025032410071712000_r10) 2010; 405 Dong (2025032410071712000_r12) 2011; 118 Buranapraditkun (2025032410071712000_r19) 2011; 6 Goonetilleke (2025032410071712000_r22) 2009; 206 Zemmour (2025032410071712000_r33) 1992; 176 Corrah (2025032410071712000_r26) 2011; 85 Honda (2025032410071712000_r20) 2011; 41 Almeida (2025032410071712000_r21) 2011; 187 Strange (2025032410071712000_r31) 2010; 42 Blais (2025032410071712000_r29) 2011; 133 Ahlenstiel (2025032410071712000_r25) 2008; 118 Specht (2025032410071712000_r18) 2010; 84 Pereyra (2025032410071712000_r3) 2010; 330 Rauch (2025032410071712000_r15) 2009; 50 Kawashima (2025032410071712000_r16) 2009; 458 Makadzange (2025032410071712000_r9) 2010; 40 Zhang (2025032410071712000_r24) 2011; 187 Shrestha (2025032410071712000_r11) 2009; 23 Adnan (2025032410071712000_r8) 2006; 108 Fellay (2025032410071712000_r1) 2009; 5 Fellay (2025032410071712000_r2) 2007; 317 Leslie (2025032410071712000_r23) 2004; 10 Kulpa (2025032410071712000_r35) 2011; 134 Nair (2025032410071712000_r30) 2009; 41 Thomas (2025032410071712000_r4) 2009; 41 Dong (2025032410071712000_r14) 2004; 200 Lie (2025032410071712000_r32) 1990; 344 Cohen (2025032410071712000_r7) 1999; 10 Kiepiela (2025032410071712000_r17) 2004; 432 Catano (2025032410071712000_r5) 2008; 3 Fellay (2025032410071712000_r27) 2010; 6 |
References_xml | – volume: 41 start-page: 1290 year: 2009 ident: 2025032410071712000_r4 article-title: HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C publication-title: Nat. Genet. doi: 10.1038/ng.486 – volume: 296 start-page: 1439 year: 2002 ident: 2025032410071712000_r13 article-title: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level publication-title: Science doi: 10.1126/science.1069660 – volume: 330 start-page: 1551 year: 2010 ident: 2025032410071712000_r3 article-title: The major genetic determinants of HIV-1 control affect HLA class I peptide presentation publication-title: Science doi: 10.1126/science.1195271 – volume: 176 start-page: 937 year: 1992 ident: 2025032410071712000_r33 article-title: Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C publication-title: J. Exp. Med. doi: 10.1084/jem.176.4.937 – volume: 3 start-page: e3636 year: 2008 ident: 2025032410071712000_r5 article-title: HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles publication-title: PLoS ONE doi: 10.1371/journal.pone.0003636 – volume: 405 start-page: 483 year: 2010 ident: 2025032410071712000_r10 article-title: Immunodominant HIV-1-specific HLA-B- and HLA-C-restricted CD8+ T cells do not differ in polyfunctionality publication-title: Virology doi: 10.1016/j.virol.2010.06.002 – volume: 108 start-page: 3414 year: 2006 ident: 2025032410071712000_r8 article-title: Nef interference with HIV-1-specific CTL antiviral activity is epitope specific publication-title: Blood doi: 10.1182/blood-2006-06-030668 – volume: 42 start-page: 985 year: 2010 ident: 2025032410071712000_r31 article-title: A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 publication-title: Nat. Genet. doi: 10.1038/ng.694 – volume: 5 start-page: e1000791 year: 2009 ident: 2025032410071712000_r1 article-title: Common genetic variation and the control of HIV-1 in humans publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1000791 – volume: 432 start-page: 769 year: 2004 ident: 2025032410071712000_r17 article-title: Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA publication-title: Nature doi: 10.1038/nature03113 – volume: 11 start-page: 1221 year: 1995 ident: 2025032410071712000_r28 article-title: The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA publication-title: AIDS Res. Hum. Retroviruses doi: 10.1089/aid.1995.11.1221 – volume: 40 start-page: 1036 year: 2010 ident: 2025032410071712000_r9 article-title: Characterization of an HLA-C-restricted CTL response in chronic HIV infection publication-title: Eur. J. Immunol. doi: 10.1002/eji.200939634 – volume: 10 start-page: 282 year: 2004 ident: 2025032410071712000_r23 article-title: HIV evolution: CTL escape mutation and reversion after transmission publication-title: Nat. Med. doi: 10.1038/nm992 – volume: 458 start-page: 641 year: 2009 ident: 2025032410071712000_r16 article-title: Adaptation of HIV-1 to human leukocyte antigen class I publication-title: Nature doi: 10.1038/nature07746 – volume: 41 start-page: 97 year: 2011 ident: 2025032410071712000_r20 article-title: Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication publication-title: Eur. J. Immunol. doi: 10.1002/eji.201040841 – volume: 6 start-page: e23603 year: 2011 ident: 2025032410071712000_r19 article-title: A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais publication-title: PLoS ONE doi: 10.1371/journal.pone.0023603 – volume: 84 start-page: 7300 year: 2010 ident: 2025032410071712000_r18 article-title: Counteraction of HLA-C-mediated immune control of HIV-1 by Nef publication-title: J. Virol. doi: 10.1128/JVI.00619-10 – volume: 472 start-page: 495 year: 2011 ident: 2025032410071712000_r6 article-title: Differential microRNA regulation of HLA-C expression and its association with HIV control publication-title: Nature doi: 10.1038/nature09914 – volume: 317 start-page: 944 year: 2007 ident: 2025032410071712000_r2 article-title: A whole-genome association study of major determinants for host control of HIV-1 publication-title: Science doi: 10.1126/science.1143767 – volume: 118 start-page: 1017 year: 2008 ident: 2025032410071712000_r25 article-title: Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses publication-title: J. Clin. Invest. – volume: 50 start-page: 1017 year: 2009 ident: 2025032410071712000_r15 article-title: Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure publication-title: Hepatology doi: 10.1002/hep.23101 – volume: 344 start-page: 439 year: 1990 ident: 2025032410071712000_r32 article-title: Peptide ligand-induced conformation and surface expression of the Ld class I MHC molecule publication-title: Nature doi: 10.1038/344439a0 – volume: 206 start-page: 1253 year: 2009 ident: 2025032410071712000_r22 article-title: The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection publication-title: J. Exp. Med. doi: 10.1084/jem.20090365 – volume: 118 start-page: 98 year: 2011 ident: 2025032410071712000_r12 article-title: Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China publication-title: Blood doi: 10.1182/blood-2010-06-291963 – volume: 6 start-page: e1001033 year: 2010 ident: 2025032410071712000_r27 article-title: Host genetics and HIV-1: the final phase? publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1001033 – volume: 133 start-page: 1 year: 2011 ident: 2025032410071712000_r29 article-title: HLA-C as a mediator of natural killer and T-cell activation: spectator or key player? publication-title: Immunology doi: 10.1111/j.1365-2567.2011.03422.x – volume: 187 start-page: 684 year: 2011 ident: 2025032410071712000_r24 article-title: Multilayered defense in HLA-B51-associated HIV viral control publication-title: J. Immunol. doi: 10.4049/jimmunol.1100316 – volume: 41 start-page: 199 year: 2009 ident: 2025032410071712000_r30 article-title: Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways publication-title: Nat. Genet. doi: 10.1038/ng.311 – volume: 187 start-page: 2502 year: 2011 ident: 2025032410071712000_r21 article-title: Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes publication-title: J. Immunol. doi: 10.4049/jimmunol.1100691 – volume: 85 start-page: 3367 year: 2011 ident: 2025032410071712000_r26 article-title: Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression publication-title: J. Virol. doi: 10.1128/JVI.02276-10 – volume: 23 start-page: 673 year: 2009 ident: 2025032410071712000_r11 article-title: Host genetics and HIV-1 viral load set-point in African-Americans publication-title: AIDS doi: 10.1097/QAD.0b013e328325d414 – volume: 10 start-page: 661 year: 1999 ident: 2025032410071712000_r7 article-title: The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells publication-title: Immunity doi: 10.1016/S1074-7613(00)80065-5 – volume: 181 start-page: 6770 year: 2008 ident: 2025032410071712000_r34 article-title: Adaptable TCR avidity thresholds for negative selection publication-title: J. Immunol. doi: 10.4049/jimmunol.181.10.6770 – volume: 200 start-page: 1547 year: 2004 ident: 2025032410071712000_r14 article-title: HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor publication-title: J. Exp. Med. doi: 10.1084/jem.20032044 – volume: 134 start-page: 116 year: 2011 ident: 2025032410071712000_r35 article-title: The emerging role of HLA-C in HIV-1 infection publication-title: Immunology doi: 10.1111/j.1365-2567.2011.03474.x |
SSID | ssj0006024 |
Score | 2.2680106 |
Snippet | Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression... Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 4663 |
SubjectTerms | 3' Untranslated Regions - genetics 3' Untranslated Regions - immunology Acquired Immunodeficiency Syndrome - epidemiology Acquired Immunodeficiency Syndrome - genetics Acquired Immunodeficiency Syndrome - immunology Acquired Immunodeficiency Syndrome - metabolism Alleles Asian People CD8-Positive T-Lymphocytes - immunology CD8-Positive T-Lymphocytes - metabolism China - epidemiology DNA, Viral - genetics DNA, Viral - immunology DNA, Viral - metabolism Female Gene Expression Regulation - genetics Gene Expression Regulation - immunology HIV-1 - genetics HIV-1 - immunology HIV-1 - metabolism HLA-C Antigens - biosynthesis HLA-C Antigens - genetics HLA-C Antigens - immunology Human immunodeficiency virus 1 Humans Interferon-gamma - genetics Interferon-gamma - immunology Interferon-gamma - metabolism Male Mutation Polymorphism, Genetic Proviruses - genetics Proviruses - immunology Proviruses - metabolism Retrospective Studies |
Title | High Frequency of HIV Mutations Associated with HLA-C Suggests Enhanced HLA-C–Restricted CTL Selective Pressure Associated with an AIDS-Protective Polymorphism |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22474021 https://www.proquest.com/docview/1008828562 https://www.proquest.com/docview/1014110095 https://pubmed.ncbi.nlm.nih.gov/PMC3378658 |
Volume | 188 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKEIgXBANG-ZKR4AGhsKR2EvuxbJ06aAeCVhpPUT6cdagkqB9I45_hlT-Tu9hO0xZNgz5Erevabe-X853v_DtCXrAwdHnmJY5UqXB47seODDLmyATZs3KmfFUlyJ4E_TF_d-qftlq_G1lLy0XyJv3513Ml_yNVaAO54inZf5BsPSg0wHOQL1xBwnC9kowxSQNMT50NXYXK--DNDZcLk99m_3ubYt4fdB1MxDnDoNL8da-Y6Ph_1e58UljDI8XeB6MBaJGpVobmCOFMbY0HuqF7fPjZ-ajJHqq-5fTiWwnCs9SEX1dwbBi_53gsRdM_vayCbG5jS-LtNNbMB0N05J3ejxp89fb2l7I4m5Rm1a3iRXPc0zfoWyUV4Y5U1dqPZybh2WxxYK6ITShsHDnwQl23Y6W2RQOfsqGEeWB0pjIvdWmSzcWCg3OEi4X5xXgggnFdR2idl_vkQ3Q0HgyiUe90dI1c74BDgrUyDo_f12t-4Ha45aXHL6oD4jjD_ub46wbQllezmZzbsHZGd8htIyna1Zi7S1qq2CU3dOHSi11yc2hSMu6RXwhCWoOQljkFENIahHQFGoqgoRXYqAUhtSCkmyCkAEJag5BaEG6NFxd0A4S0CcL7ZHzUGx30HVP1w0nBNlo4DHyC2A9lKpUMfDCvpZ-5YZrD2sTdmKUui8PEAzWCFJoqzAKRiCzw8izmGTwke0B2irJQDwnlgolMeqGXS8VdlgkB7jrnTIjM6yg3aJN9K4ooNZT4WJllGoFrjMKLrPAiI7w2eVV_4rumg7mk73Mr3Qh0Ngbi4kKVyznyhAtkjgwu7eNxpHOUfpvsaUTUM4LZHXIwztskXMNK3QE549ffKc4nFXc8Y6EAp-PRFeZ9TG6tbsYnZGcxW6qnYIEvkmcV-P8Am6zhHA |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+Frequency+of+HIV+Mutations+Associated+with+HLA-C+Suggests+Enhanced+HLA-C-Restricted+CTL+Selective+Pressure+Associated+with+an+AIDS-Protective+Polymorphism&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Blais%2C+Marie-Eve&rft.au=Zhang%2C+Yonghong&rft.au=Rostron%2C+Tim&rft.au=Griffin%2C+Harry&rft.date=2012-05-01&rft.issn=0022-1767&rft.volume=188&rft.issue=9&rft.spage=4663&rft.epage=4670&rft_id=info:doi/10.4049%2Fjimmunol.1103472&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon |